ArticleBreast cancer research : BCR2025
Deep learning-powered multi-parametric ultrasound for classifying metastatic versus reactive axillary lymph nodes.
Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo propose a multi-parametric ultrasound imaging-based deep learning method for accurately classifying metastatic and non-metastatic axillary lymph nodes in breast cancer patients.
methodsThe proposed method integrates the conventional ultrasound B-mode imaging with shear wave elastography and color Doppler images of 174 patients to train a transfer learning-based network comprising pretrained MobileNetv2 with a custom shallow head consisting of a convolutional neural network with mixed pooling, weighted sum mixed pooling and squeeze-and-excite attention mechanisms for the first time in the context of ALN classification.
resultsThe proposed method was evaluated using five-fold cross-validation, achieving a mean classification accuracy of 0.91, specificity of 0.91, sensitivity of 0.93, F1 score of 0.93, area under the precision-recall curve of 0.94, and a cross-validated AUC (cvAUC) of 0.92. A network ablation study confirmed the robustness of the model, with relatively narrow 95% confidence intervals (CIs) for cvAUC. Comparative analysis showed that the proposed network (Acc: 0.91) outperformed state-of-the-art deep learning models (Acc: 0.67-0.88) for ALN classification and exhibited narrower CIs, highlighting its relative stability. Additionally, results demonstrated that multi-parametric imaging significantly enhanced classification performance, reducing the 95% CI width by nearly half compared to uni-parametric data, further supporting the method's robustness and reliability.
conclusionThe integration of multi-parametric ultrasound imaging with deep learning network can remarkably improve the classification of metastatic and non-metastatic ALNs in breast cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.